Cargando…

Type III CRISPR-Cas complexes act as protein-assisted ribozymes during target RNA cleavage

CRISPR-Cas systems are an adaptive immune system in bacteria and archaea that utilize CRISPR RNA-guided surveillance complexes to target complementary RNA or DNA for destruction(1–5). Target RNA cleavage at regular intervals is characteristic of type III effector complexes; however, the mechanism ha...

Descripción completa

Detalles Bibliográficos
Autores principales: Schwartz, Evan A., Bravo, Jack P.K., Ahsan, Mohd, Macias, Luis A., McCafferty, Caitlyn L., Dangerfield, Tyler L., Walker, Jada N., Brodbelt, Jennifer S., Palermo, Giulia, Fineran, Peter C., Fagerlund, Robert D., Taylor, David W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Journal Experts 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10168453/
https://www.ncbi.nlm.nih.gov/pubmed/37163044
http://dx.doi.org/10.21203/rs.3.rs-2837968/v1
_version_ 1785038856911847424
author Schwartz, Evan A.
Bravo, Jack P.K.
Ahsan, Mohd
Macias, Luis A.
McCafferty, Caitlyn L.
Dangerfield, Tyler L.
Walker, Jada N.
Brodbelt, Jennifer S.
Palermo, Giulia
Fineran, Peter C.
Fagerlund, Robert D.
Taylor, David W.
author_facet Schwartz, Evan A.
Bravo, Jack P.K.
Ahsan, Mohd
Macias, Luis A.
McCafferty, Caitlyn L.
Dangerfield, Tyler L.
Walker, Jada N.
Brodbelt, Jennifer S.
Palermo, Giulia
Fineran, Peter C.
Fagerlund, Robert D.
Taylor, David W.
author_sort Schwartz, Evan A.
collection PubMed
description CRISPR-Cas systems are an adaptive immune system in bacteria and archaea that utilize CRISPR RNA-guided surveillance complexes to target complementary RNA or DNA for destruction(1–5). Target RNA cleavage at regular intervals is characteristic of type III effector complexes; however, the mechanism has remained enigmatic(6,7). Here, we determine the structures of the Synechocystis type III-Dv complex, an evolutionary intermediate in type III effectors(8,9), in pre- and post-cleavage states, which show metal ion coordination in the active sites. Using structural, biochemical, and quantum/classical molecular dynamics simulation, we reveal the structure and dynamics of the three catalytic sites, where a 2’-OH of the ribose on the target RNA acts as a nucleophile for in line self-cleavage of the upstream scissile phosphate. Strikingly, the arrangement at the catalytic residues of most type III complexes resembles the active site of ribozymes, including the hammerhead, pistol, and Varkud satellite ribozymes. Thus, type III CRISPR-Cas complexes function as protein-assisted ribozymes, and their programmable nature has important implications for how these complexes could be repurposed for applications.
format Online
Article
Text
id pubmed-10168453
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher American Journal Experts
record_format MEDLINE/PubMed
spelling pubmed-101684532023-05-10 Type III CRISPR-Cas complexes act as protein-assisted ribozymes during target RNA cleavage Schwartz, Evan A. Bravo, Jack P.K. Ahsan, Mohd Macias, Luis A. McCafferty, Caitlyn L. Dangerfield, Tyler L. Walker, Jada N. Brodbelt, Jennifer S. Palermo, Giulia Fineran, Peter C. Fagerlund, Robert D. Taylor, David W. Res Sq Article CRISPR-Cas systems are an adaptive immune system in bacteria and archaea that utilize CRISPR RNA-guided surveillance complexes to target complementary RNA or DNA for destruction(1–5). Target RNA cleavage at regular intervals is characteristic of type III effector complexes; however, the mechanism has remained enigmatic(6,7). Here, we determine the structures of the Synechocystis type III-Dv complex, an evolutionary intermediate in type III effectors(8,9), in pre- and post-cleavage states, which show metal ion coordination in the active sites. Using structural, biochemical, and quantum/classical molecular dynamics simulation, we reveal the structure and dynamics of the three catalytic sites, where a 2’-OH of the ribose on the target RNA acts as a nucleophile for in line self-cleavage of the upstream scissile phosphate. Strikingly, the arrangement at the catalytic residues of most type III complexes resembles the active site of ribozymes, including the hammerhead, pistol, and Varkud satellite ribozymes. Thus, type III CRISPR-Cas complexes function as protein-assisted ribozymes, and their programmable nature has important implications for how these complexes could be repurposed for applications. American Journal Experts 2023-04-27 /pmc/articles/PMC10168453/ /pubmed/37163044 http://dx.doi.org/10.21203/rs.3.rs-2837968/v1 Text en https://creativecommons.org/licenses/by/4.0/This work is licensed under a Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/) , which allows reusers to distribute, remix, adapt, and build upon the material in any medium or format, so long as attribution is given to the creator. The license allows for commercial use.
spellingShingle Article
Schwartz, Evan A.
Bravo, Jack P.K.
Ahsan, Mohd
Macias, Luis A.
McCafferty, Caitlyn L.
Dangerfield, Tyler L.
Walker, Jada N.
Brodbelt, Jennifer S.
Palermo, Giulia
Fineran, Peter C.
Fagerlund, Robert D.
Taylor, David W.
Type III CRISPR-Cas complexes act as protein-assisted ribozymes during target RNA cleavage
title Type III CRISPR-Cas complexes act as protein-assisted ribozymes during target RNA cleavage
title_full Type III CRISPR-Cas complexes act as protein-assisted ribozymes during target RNA cleavage
title_fullStr Type III CRISPR-Cas complexes act as protein-assisted ribozymes during target RNA cleavage
title_full_unstemmed Type III CRISPR-Cas complexes act as protein-assisted ribozymes during target RNA cleavage
title_short Type III CRISPR-Cas complexes act as protein-assisted ribozymes during target RNA cleavage
title_sort type iii crispr-cas complexes act as protein-assisted ribozymes during target rna cleavage
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10168453/
https://www.ncbi.nlm.nih.gov/pubmed/37163044
http://dx.doi.org/10.21203/rs.3.rs-2837968/v1
work_keys_str_mv AT schwartzevana typeiiicrisprcascomplexesactasproteinassistedribozymesduringtargetrnacleavage
AT bravojackpk typeiiicrisprcascomplexesactasproteinassistedribozymesduringtargetrnacleavage
AT ahsanmohd typeiiicrisprcascomplexesactasproteinassistedribozymesduringtargetrnacleavage
AT maciasluisa typeiiicrisprcascomplexesactasproteinassistedribozymesduringtargetrnacleavage
AT mccaffertycaitlynl typeiiicrisprcascomplexesactasproteinassistedribozymesduringtargetrnacleavage
AT dangerfieldtylerl typeiiicrisprcascomplexesactasproteinassistedribozymesduringtargetrnacleavage
AT walkerjadan typeiiicrisprcascomplexesactasproteinassistedribozymesduringtargetrnacleavage
AT brodbeltjennifers typeiiicrisprcascomplexesactasproteinassistedribozymesduringtargetrnacleavage
AT palermogiulia typeiiicrisprcascomplexesactasproteinassistedribozymesduringtargetrnacleavage
AT fineranpeterc typeiiicrisprcascomplexesactasproteinassistedribozymesduringtargetrnacleavage
AT fagerlundrobertd typeiiicrisprcascomplexesactasproteinassistedribozymesduringtargetrnacleavage
AT taylordavidw typeiiicrisprcascomplexesactasproteinassistedribozymesduringtargetrnacleavage